Published in Stem Cells on January 01, 2005
Assessment of therapeutic efficacy and fate of engineered human mesenchymal stem cells for cancer therapy. Proc Natl Acad Sci U S A (2009) 2.47
Mesenchymal stem cell delivery of TRAIL can eliminate metastatic cancer. Cancer Res (2009) 2.09
Antigen-presenting property of mesenchymal stem cells occurs during a narrow window at low levels of interferon-gamma. Blood (2006) 1.79
Magnetic resonance imaging of mesenchymal stem cells homing to pulmonary metastases using biocompatible magnetic nanoparticles. Cancer Res (2009) 1.42
Potential of mesenchymal stem cells in gene therapy approaches for inherited and acquired diseases. Expert Opin Biol Ther (2005) 1.24
Stem cells as vectors for antitumour therapy. Thorax (2010) 1.14
Bone marrow-derived mesenchymal stem cells promote growth and angiogenesis of breast and prostate tumors. Stem Cell Res Ther (2013) 1.09
Biological characteristics of stem cells from foetal, cord blood and extraembryonic tissues. J R Soc Interface (2010) 1.06
Developing cell therapy techniques for respiratory disease: intratracheal delivery of genetically engineered stem cells in a murine model of airway injury. Hum Gene Ther (2009) 1.01
Multivariate biophysical markers predictive of mesenchymal stromal cell multipotency. Proc Natl Acad Sci U S A (2014) 1.01
Growth inhibition of colorectal carcinoma by lentiviral TRAIL-transgenic human mesenchymal stem cells requires their substantial intratumoral presence. J Cell Mol Med (2010) 0.92
Concise review: Nanoparticles and cellular carriers-allies in cancer imaging and cellular gene therapy? Stem Cells (2010) 0.92
Comparative Evaluation of Human Mesenchymal Stem Cells of Fetal (Wharton's Jelly) and Adult (Adipose Tissue) Origin during Prolonged In Vitro Expansion: Considerations for Cytotherapy. Stem Cells Int (2013) 0.90
Systemic but not topical TRAIL-expressing mesenchymal stem cells reduce tumour growth in malignant mesothelioma. Thorax (2014) 0.88
Mesenchymal stem cells: emerging therapy for Duchenne muscular dystrophy. PM R (2009) 0.86
Osteogenic differentiation of mesenchymal stem cells promoted by overexpression of connective tissue growth factor. J Zhejiang Univ Sci B (2009) 0.86
The immunomodulatory properties of mesenchymal stem cells: implications for surgical disease. J Surg Res (2010) 0.83
The Future of Prenatal Diagnosis and Screening. J Clin Med (2014) 0.83
Extended and stable gene expression via nucleofection of MIDGE construct into adult human marrow mesenchymal stromal cells. Cytotechnology (2011) 0.82
Robust, efficient, and practical electrogene transfer method for human mesenchymal stem cells using square electric pulses. Hum Gene Ther Methods (2013) 0.81
Prenatal transplantation of mesenchymal stem cells to treat osteogenesis imperfecta. Front Pharmacol (2014) 0.80
Human mesenchymal stem cells derived from limb bud can differentiate into all three embryonic germ layers lineages. Cell Reprogram (2012) 0.80
Genetically modified mesenchymal stromal cells in cancer therapy. Cytotherapy (2016) 0.77
Susceptibility of human placenta derived mesenchymal stromal/stem cells to human herpesviruses infection. PLoS One (2013) 0.77
Long-term reproducible expression in human fetal liver hematopoietic stem cells with a UCOE-based lentiviral vector. PLoS One (2014) 0.77
Hyperthermia treatment of tumors by mesenchymal stem cell-delivered superparamagnetic iron oxide nanoparticles. Int J Nanomedicine (2016) 0.77
Fetal vs adult mesenchymal stem cells achieve greater gene expression, but less osteoinduction. World J Stem Cells (2015) 0.77
Helicobacter pylori-infected MSCs acquire a pro-inflammatory phenotype and induce human gastric cancer migration by promoting EMT in gastric cancer cells. Oncol Lett (2015) 0.77
In vivo gene activity of human mesenchymal stem cells after scaffold-mediated local transplantation. Tissue Eng Part A (2014) 0.75
IL-17B activated mesenchymal stem cells enhance proliferation and migration of gastric cancer cells. Oncotarget (2017) 0.75
Human fetal mesenchymal stem cell secretome enhances bone consolidation in distraction osteogenesis. Stem Cell Res Ther (2016) 0.75
In Utero Transfer of Adeno-Associated Viral Vectors Produces Long-Term Factor IX Levels in a Cynomolgus Macaque Model. Mol Ther (2017) 0.75
Stem cell function, self-renewal, and behavioral heterogeneity of cells from the adult muscle satellite cell niche. Cell (2005) 7.15
Local restoration of dystrophin expression with the morpholino oligomer AVI-4658 in Duchenne muscular dystrophy: a single-blind, placebo-controlled, dose-escalation, proof-of-concept study. Lancet Neurol (2009) 5.35
Predictable progressive Doppler deterioration in IUGR: does it really exist? Am J Obstet Gynecol (2013) 3.41
Microchimerism in female bone marrow and bone decades after fetal mesenchymal stem-cell trafficking in pregnancy. Lancet (2004) 2.56
Increased stillbirth in uncomplicated monochorionic twin pregnancies: a systematic review and meta-analysis. Obstet Gynecol (2013) 2.08
Human first-trimester fetal MSC express pluripotency markers and grow faster and have longer telomeres than adult MSC. Stem Cells (2006) 2.04
A population of myogenic stem cells that survives skeletal muscle aging. Stem Cells (2007) 2.03
Are 1st-trimester β-human chorionic gonadotrophin and pregnancy-associated plasma protein A levels predictive of intrapartum fetal compromise in a selected normal population? Aust N Z J Obstet Gynaecol (2014) 1.96
The role of hydroxyurea in sickle cell disease. Br J Haematol (2003) 1.69
PLUTO trial protocol: percutaneous shunting for lower urinary tract obstruction randomised controlled trial. BJOG (2007) 1.55
Abnormalities in the myeloid progenitor compartment in Down syndrome fetal liver precede acquisition of GATA1 mutations. Blood (2008) 1.54
Superior osteogenic capacity for bone tissue engineering of fetal compared with perinatal and adult mesenchymal stem cells. Stem Cells (2009) 1.49
A randomized trial of amnioreduction versus septostomy in the treatment of twin-twin transfusion syndrome. Am J Obstet Gynecol (2005) 1.48
Fetal cystoscopy in the management of fetal obstructive uropathy: experience in a single European centre. Prenat Diagn (2003) 1.46
Perturbation of fetal liver hematopoietic stem and progenitor cell development by trisomy 21. Proc Natl Acad Sci U S A (2012) 1.46
Academic health science centres in Australia: let's get competitive. Med J Aust (2011) 1.43
Small molecule mesengenic induction of human induced pluripotent stem cells to generate mesenchymal stem/stromal cells. Stem Cells Transl Med (2012) 1.41
Cardiovascular and endocrine responses to cutaneous electrical stimulation after fentanyl in the ovine fetus. Am J Obstet Gynecol (2004) 1.40
Amniocentesis in the third trimester of pregnancy. Prenat Diagn (2007) 1.39
Single fibers of skeletal muscle as a novel graft for cell transplantation to the heart. J Thorac Cardiovasc Surg (2002) 1.37
Muscle satellite cells are a functionally heterogeneous population in both somite-derived and branchiomeric muscles. Dev Biol (2009) 1.37
Expansion of revertant fibers in dystrophic mdx muscles reflects activity of muscle precursor cells and serves as an index of muscle regeneration. J Cell Sci (2006) 1.34
Revertant fibres and dystrophin traces in Duchenne muscular dystrophy: implication for clinical trials. Neuromuscul Disord (2010) 1.34
Contribution of human muscle-derived cells to skeletal muscle regeneration in dystrophic host mice. PLoS One (2011) 1.31
Restoration of the dystrophin-associated glycoprotein complex after exon skipping therapy in Duchenne muscular dystrophy. Mol Ther (2011) 1.30
Intrauterine transplantation of human fetal mesenchymal stem cells from first-trimester blood repairs bone and reduces fractures in osteogenesis imperfecta mice. Blood (2007) 1.25
Release of reactive oxygen and nitrogen species from contracting skeletal muscle cells. Free Radic Biol Med (2004) 1.24
Are human and mouse satellite cells really the same? J Histochem Cytochem (2010) 1.21
Steroids in Duchenne muscular dystrophy: from clinical trials to genomic research. Neuromuscul Disord (2002) 1.21
Widespread distribution and muscle differentiation of human fetal mesenchymal stem cells after intrauterine transplantation in dystrophic mdx mouse. Stem Cells (2006) 1.18
Non-invasive fetal electrocardiography in singleton and multiple pregnancies. BJOG (2003) 1.18
Dystrophin quantification and clinical correlations in Becker muscular dystrophy: implications for clinical trials. Brain (2011) 1.17
Dystromirs as serum biomarkers for monitoring the disease severity in Duchenne muscular Dystrophy. PLoS One (2013) 1.16
Poly(A)-specific ribonuclease deficiency impacts telomere biology and causes dyskeratosis congenita. J Clin Invest (2015) 1.16
Integrated functions of Pax3 and Pax7 in the regulation of proliferation, cell size and myogenic differentiation. PLoS One (2009) 1.15
Accurate and robust quantification of circulating fetal and total DNA in maternal plasma from 5 to 41 weeks of gestation. Clin Chem (2004) 1.13
Microchimeric fetal cells cluster at sites of tissue injury in lung decades after pregnancy. Reprod Biomed Online (2008) 1.13
Transplantation of human fetal blood stem cells in the osteogenesis imperfecta mouse leads to improvement in multiscale tissue properties. Blood (2010) 1.12
Optimizing the definition of intrauterine growth restriction: the multicenter prospective PORTO Study. Am J Obstet Gynecol (2013) 1.12
The potential of human fetal mesenchymal stem cells for off-the-shelf bone tissue engineering application. Biomaterials (2012) 1.10
Valproic acid confers functional pluripotency to human amniotic fluid stem cells in a transgene-free approach. Mol Ther (2012) 1.10
Galectin-1 induces skeletal muscle differentiation in human fetal mesenchymal stem cells and increases muscle regeneration. Stem Cells (2006) 1.09
Fetal stem cells. Best Pract Res Clin Obstet Gynaecol (2004) 1.08
Pre- and postnatal transplantation of fetal mesenchymal stem cells in osteogenesis imperfecta: a two-center experience. Stem Cells Transl Med (2013) 1.08
Neo-vascularization and bone formation mediated by fetal mesenchymal stem cell tissue-engineered bone grafts in critical-size femoral defects. Biomaterials (2009) 1.07
A biomarker-based mathematical model to predict bone-forming potency of human synovial and periosteal mesenchymal stem cells. Arthritis Rheum (2008) 1.06
A-utrophin up-regulation in mdx skeletal muscle is independent of regeneration. Neuromuscul Disord (2004) 1.05
Extracellular microRNAs are dynamic non-vesicular biomarkers of muscle turnover. Nucleic Acids Res (2013) 1.05
Pregnancy loss managed by cervical dilatation and curettage increases the risk of spontaneous preterm birth. Hum Reprod (2013) 1.04
Comparative osteogenic transcription profiling of various fetal and adult mesenchymal stem cell sources. Differentiation (2008) 1.01
MR imaging methods for assessing fetal brain development. Dev Neurobiol (2008) 1.01
Myf5 expression in satellite cells and spindles in adult muscle is controlled by separate genetic elements. Dev Biol (2004) 1.00
Stable human FIX expression after 0.9G intrauterine gene transfer of self-complementary adeno-associated viral vector 5 and 8 in macaques. Mol Ther (2011) 1.00
Fetomaternal cell trafficking and the stem cell debate: gender matters. JAMA (2007) 0.99
Upregulating CXCR4 in human fetal mesenchymal stem cells enhances engraftment and bone mechanics in a mouse model of osteogenesis imperfecta. Stem Cells Transl Med (2011) 0.99
The effects of culture on genomic imprinting profiles in human embryonic and fetal mesenchymal stem cells. Epigenetics (2011) 0.98
Donor satellite cell engraftment is significantly augmented when the host niche is preserved and endogenous satellite cells are incapacitated. Stem Cells (2012) 0.98
Differentiation of human fetal mesenchymal stem cells into cells with an oligodendrocyte phenotype. Cell Cycle (2009) 0.98
Glycosylphosphatidylinositol-specific, CD1d-restricted T cells in paroxysmal nocturnal hemoglobinuria. Blood (2013) 0.98
Recent progress in satellite cell/myoblast engraftment -- relevance for therapy. FEBS J (2013) 0.96
Stem cell differentiation and expansion for clinical applications of tissue engineering. J Cell Mol Med (2007) 0.96
Hyperhemolysis syndrome in sickle cell disease: case report (recurrent episode) and literature review. Transfusion (2008) 0.96
Intracellular trafficking and endocytosis of CXCR4 in fetal mesenchymal stem/stromal cells. BMC Cell Biol (2014) 0.96
Regeneration of skeletal muscle from transplanted immortalised myoblasts is oligoclonal. J Cell Sci (2004) 0.95
Fetal stem cells: betwixt and between. Semin Reprod Med (2006) 0.95
The human desmin locus: gene organization and LCR-mediated transcriptional control. Genomics (2006) 0.95
Tartrate-resistant acid phosphatase isoform 5b: a novel serum marker for monitoring bone disease in multiple myeloma. Int J Cancer (2003) 0.94
Twin-twin transfusion--as good as it gets? N Engl J Med (2004) 0.94
Pregnancy and the risk of autoimmune disease. PLoS One (2011) 0.93
Exome sequencing identifies MPL as a causative gene in familial aplastic anemia. Haematologica (2011) 0.93
Stem cells to treat muscular dystrophies - where are we? Neuromuscul Disord (2010) 0.92
Defects in glycosylation impair satellite stem cell function and niche composition in the muscles of the dystrophic Large(myd) mouse. Stem Cells (2012) 0.92
Ontological differences in first compared to third trimester human fetal placental chorionic stem cells. PLoS One (2012) 0.91
Target enrichment and high-throughput sequencing of 80 ribosomal protein genes to identify mutations associated with Diamond-Blackfan anaemia. Br J Haematol (2013) 0.91
Fetal growth restriction and the risk of perinatal mortality-case studies from the multicentre PORTO study. BMC Pregnancy Childbirth (2014) 0.90
Fetal stem cell microchimerism: natural-born healers or killers? Mol Hum Reprod (2010) 0.90
First trimester embryo-fetoscopic and ultrasound-guided fetal blood sampling for ex vivo viral transduction of cultured human fetal mesenchymal stem cells. Hum Reprod (2008) 0.90
Osterix induces osteogenic gene expression but not differentiation in primary human fetal mesenchymal stem cells. Tissue Eng (2007) 0.89
Fetal cells in the maternal appendix: a marker of inflammation or fetal tissue repair? Hum Reprod (2008) 0.88
Serial aggressive platelet transfusion for fetal alloimmune thrombocytopenia: platelet dynamics and perinatal outcome. Am J Obstet Gynecol (2002) 0.88
Human mid-trimester amniotic fluid stem cells cultured under embryonic stem cell conditions with valproic acid acquire pluripotent characteristics. Stem Cells Dev (2012) 0.88
The contribution of human synovial stem cells to skeletal muscle regeneration. Neuromuscul Disord (2010) 0.87
High frequency of fetal cells within a primitive stem cell population in maternal blood. Hum Reprod (2008) 0.87
Temporal and geographical variation in UK obstetricians' personal preference regarding mode of delivery. Eur J Obstet Gynecol Reprod Biol (2002) 0.87
Noninvasive fetal RHD genotyping by microfluidics digital PCR using maternal plasma from two alloimmunized women with the variant RHD(IVS3+1G>A) allele. Prenat Diagn (2013) 0.87
The natural history of anencephaly. Prenat Diagn (2010) 0.87
High risk of unexpected late fetal death in monochorionic twins despite intensive ultrasound surveillance: a cohort study. PLoS Med (2005) 0.87